Assessment of transition readiness skills and adherence in pediatric liver transplant recipients by Fredericks, Emily M. et al.
Assessment of transition readiness skills
and adherence in pediatric liver transplant
recipients
With increased short-term survival rates among
pediatric solid organ transplant recipients, health
care providers have shifted focus to long-term
outcomes. Long-term patient survival is limited
by chronic rejection and graft loss, which is more
common in adolescents (1). There is also an
increased risk for medical complications follow-
ing the transfer from pediatric to adult-centered
transplant services (2). Thus, there is a critical
need to develop strategies to assess the readiness
to move from pediatric to adult-centered care
(3–6).
‘‘Transition’’ is an active process that
addresses the medical, psychosocial, and educa-
tional/vocational needs of adolescents as they
prepare to move from child- to adult-centered
health care (7), while ‘‘transfer’’ refers to the
change in the location where care is provided
(8, 9). The transition process is twofold as it
includes the transition of responsibility for health
care tasks from the parent to the patient, as well
as the preparation to transfer to adult-centered
care. Beginning in late childhood/early adoles-
cence, the management of a chronic illness begins
to shift from the primary responsibility of the
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Abstract: To examine transition readiness, adherence, and health out-
comes in pediatric liver transplant recipients using a clinically admin-
istered screening measure. Seventy-one pediatric liver transplant
recipients (11–20 yr) and 58 parents completed a clinic-based TRS
measuring perceived and demonstrated self-management skills, AoR for
health-related tasks, regimen knowledge, and psychosocial adjustment.
Adherence was measured using s.d. of immunosuppressants, proportion
of immunosuppressant blood levels out of target range, and clinic
attendance. Health outcomes included liver test panels, biopsies, rejec-
tion episodes, and hospitalizations. Results indicate that all domains of
transition readiness, with the exception of demonstrated skills, and non-
adherence were positively correlated with age. Proportion of immuno-
suppressant blood levels below target range was positively correlated
with self-management skills and increased responsibility for medication
tasks. Parent regimen knowledge was associated with clinic attendance.
Health outcomes were significantly related to medication non-adher-
ence, but not to transition readiness domains. Medication adherence is
considered to be a key factor in the transition from pediatric to adult-
centered transplant care. Non-adherence is associated with an increased
risk for medical complications and is potentially modifiable. Interven-
tions to promote self-management skills and adherence should be an
essential component of transition planning.
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parent to self-management by the adolescent
(Fig. 1) (10). By shifting responsibility for health-
related tasks in a developmentally appropriate
manner, the adolescent gains the knowledge,
skills, and experiences necessary to master the
independence required to be successful in the
adult health care system.
Self-management skills are integral to the
achievement of independence necessary for suc-
cessful health care transitions (11, 12). Research-
ers and clinicians agree that adolescents and
young adults should not transfer from pediatric
to adult health services unless they have the
skills necessary for functioning effectively in the
adult health care system, including adhering to
medication regimens (13, 14). The Pediatric
Committee of the American Society of Trans-
plantation has recommended that prior to
transferring to adult-centered care, the pediatric
transplant recipient should demonstrate the
ability to independently manage their health
(5). In addition, the pediatric patient should
adhere to their immunosuppressant medications
to avoid increased risk of graft loss and rejec-
tion following the transfer to adult-centered care
(3, 4).
The specific aims were to (i) describe A/YA
and parent responses on a clinically developed
TRS that assesses perceived and demonstrated
skills, as well as the AoR for health management
tasks and (ii) explore the relationship between the
TRS, measures of adherence, and health out-
comes. We hypothesized that higher scores on
the TRS indicated greater transition-related self-
management skills and would be associated with




Approval from the medical centers Institutional Review
Board was obtained prior to conducting a retrospective
chart review for the present cross-sectional study. A review
of the pediatric liver transplant clinic registry identified
patients who had completed the TRS since October 2007 as
part of routine follow-up in the Pediatric Liver Transplant
Clinic. Patients completed this survey if they were 11 yr of
age and older and more than six months post-transplant.
We included patients as young as 11 yr given that previous
research with pediatric liver transplant recipients found that
the transition of responsibility for health-related tasks
occurs between the ages of nine and 17 yr, with a mean age
of 12 yr (15). When present, parents completed a parallel
version of the measure.
Measures
Transition readiness
Assessment of transition readiness occurred through the use
of a clinically derived measure designed to guide individu-
alized assessment and intervention as part of transition
planning. Survey items were selected by clinical observa-
tions, review of the transition, self-management, and med-
ication adherence literature, and discussions with members
of the pediatric liver transplant team (13, 16). The team was
comprised of a pediatric hepatologist, transplant surgeon,
pediatric psychologist, social worker, dietician, and trans-
plant nurse coordinator. Administration time for the sur-
veys was approximately 15 min. The A/YA and parent
versions are described below.
TRS:A/YA
The TRS:A/YA consisted of 38 written items and four
healthcare provider administrated questions. Responses
elicited ranged from self-report using Likert scales to direct
demonstration of skills. Items were grouped conceptually
into four domains: Self-Management, Regimen Knowledge,
Demonstrated Skills, and Psychosocial Adjustment (Table 1).
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which assessed AoR in the two wk preceding the survey.
AoR was assessed using five items to examine the distribu-
tion of medication-taking responsibility between the A/YA
and the parent/caregiver. These items were adapted for use
with pediatric transplant recipients from measures used to
assess AoR in families of children diagnosed with asthma
(17) and type 1 diabetes (18). For each item, respondents
indicated the frequency of involvement of the A/YA or the
parent/caregiver.
Scoring of the TRS varied with each item and yielded a
total score of 126 with higher scores reflecting increased skill
acquisition. For items assessing perceived skills, knowledge
or attitudes, patients responded using three- or four-point
Likert scales. Higher scores reflected perceived presence of
knowledge/skills or agreement with items. Items requiring
direct observation of skills included symptom recognition
and health literacy. These were scored using percentage
correct and assigned a value on a three-point scale
(1 = <33% correct, 2 = 34–65% correct; 3 = >66%).
To further assess medication knowledge, upon completing
the written portion of the survey, patients were asked to
verbally list their medications, as well as the dosages, timing
of dose administration, and function of the medications.
Responses to each question were coded on a three-point
scale (1 = none, 2 = some, 3 = all) indicating extent of
patients knowledge.
TRS: parent report
The TRS:P consisted of 36 items yielding a total possible
score of 108. Parents were assessed on their perception of
their adolescents skills using parallel items from the A/
YA measure. Similar to the TRS:A/YA, higher scores
reflected increased perceived skills needed to transfer from
pediatric to adult-centered care. Items were grouped
conceptually into five domains (Table 1). Three domains
were proxy reports of the adolescents skills, and the
remaining two assessed parents knowledge of their ado-
lescent regimen, and demonstration of regimen knowl-
edge.
Adherence
A multi-method assessment of the adolescents adherence to
immunosuppressant medications and clinic visits in the
12 months preceding administration of the TRS was con-
ducted using a retrospective review of the patients medical
record. Adherence measures were used as continuous and
categorical variables in analyses.
Immunosuppressant levels: The degree of fluctuation in
immunosuppressant blood levels has been used to
assess the variability of medication administration, with
higher fluctuations indicating medication non-adherence
(15, 19–24). Data from routine monitoring of tacrolimus
and cyclosporine blood levels were obtained from the
participants medical record and the University of Michi-
gans OTIS for the previous year. Immunosuppressant
levels obtained during inpatient hospitalization stays
were not included in the analyses. s.d. of consecutive
blood levels obtained retrospectively were calculated. In
addition, the proportion of immunosuppressant blood
levels outside of the adolescents recommended target
therapeutic range (above and below) was also calculated
using laboratory values for the preceding 12 months. To
avoid the potential introduction of bias, adherence data
were collected in a systematic method by a research
assistant who was not involved in direct patient care.
Based on previous studies of the association between
immunosuppressant variability and risk for poor health
outcomes, such as late allograft rejection, adherence was
defined as a tacrolimus s.d. < 2 and cyclosporine s.d. < 30
(20, 22, 25, 26), and/or <50% of immunosuppressant
blood values out of the target range (15, 22). Given the
clinical context, our definitions for adherence are conser-
vative as we routinely examine variability in immunosup-
pressant blood levels to identify patients who may be at
risk for medication non-adherence.
Clinic attendance: Adherence to clinic visits was assessed
retrospectively by comparing actual clinic attendance to the
Table 1. Domains of the TRS
Domain
Number
of items Example item(s)
Adolescent report (TRS:A/YA)
Self-management 12 I wear a Medicalert ID; Who notices when prescriptions needs to be refilled?
AoR 5 In the past two wk, how often did you remember to take your medications without an adult reminding you?
How often did your parent remind you to take your medication?
Perceived regimen knowledge 10 I can name all of my medications; I know how often I need to come to appointments
Demonstrated skills 9 Name your medications; John took his morning dose of medicine at 7 AM. He takes his 2nd dose 10 h
later. What time does he take his 2nd dose?
Psychosocial adjustment 11 I have no control over my health in the future; I am limited in what I can achieve in the future because of
my transplant
Parent report (TRS:P)
Adolescent self-management 11 My child wears a Medicalert ID; Who notices when prescriptions need to be refilled?
AoR 5 In the past two wk, how often did you remind your child to take his/her medication?
Adolescent regimen knowledge 7 My child can name all of their medications; My child knows how often they need to come
to their appointments
Demonstrated skills 5 John took his morning dose of medicine at 7 AM. He takes his 2nd dose 10 h later. What time does he
take his 2nd dose?
Adolescent psychosocial adjustment 11 My child feels they have little control over their health; Because of their transplant, my child cannot pursue
certain jobs in the future
Regimen knowledge 2 My child needs to take medications for the rest of their life
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frequency recommended by the transplant team. The rate of
clinic attendance for the year prior to study participation
was obtained from the adolescents medical record. Adher-
ence was defined as a clinic attendance rate of ‡85%. This
definition is consistent with the pediatric adherence litera-
ture (27), and previous work in pediatric liver transplanta-
tion, wherein the rate of clinic attendance was significantly
related to hospital admissions, liver biopsies, and rejection
episodes (20).
Health outcomes
Measures of A/YA health outcomes including liver panel
tests (AST, ALT, TBili), graft function, frequency of hos-
pital admissions, liver biopsies, and episodes of rejection for
the year prior to study participation were obtained from a
review of medical records.
Data analysis
To examine the factorial structure of the TRS for data
interpretation, we conducted a CFA with four factors to test
the hypothesis that the TRS measured a unitary construct
underlying transition readiness. We hypothesized that the
construct was comprised of four subdomains: self-manage-
ment, regimen knowledge, demonstrated skills, and psy-
chosocial adjustment. To accomplish this, a PCA with a
varimax rotation was performed on the 38 items of the
TRS:A/YA and the 36 items of the TRS:P. Given the neg-
atively skewed distribution of the data, a non-parametric
approach with a varimax rotation was used to isolate factor
loadings that discriminate based on the explained variability
(28).
Results from the surveys were analyzed using descrip-
tive statistics (e.g., means, s.d.) to explore patterns of
transfer readiness. Pearsons product moment correlation
coefficients were calculated whenever the assumptions
underlying parametric statistical testing were met. Given
the significant skewness of the TRS, Spearmans rank
correlation coefficients were calculated to examine the
associations between scores on the TRS domains, mea-
sures of adherence, health outcomes, and demographic
factors (age, time since transplantation). All analyses were
conducted using SPSS for Windows (Version 16.0, SPSS,
Inc., Chicago, IL, USA).
Results
Participant characteristics
The total sample consisted of 71 pediatric
liver transplant recipients, which represented
approximately 98% of the clinic population in
the targeted age range. Of these, 58 (82%)
adolescents had parallel parent reports. Mean
adolescent age was 15.6 ± 2.7 yr (range 11–
20 yr) with an average time since transplant of
9.4 ± 5.4 yr (range 1–19 yr). Fifty-six percent
of the adolescents were women and 37%
belonged to a minority group. Most adoles-
cents (85%) used tacrolimus as their primary
immunosuppressant with the remainder using
cyclosporine. All adolescents were on twice-
daily dosages of their immunosuppressant
medications.
Transition readiness scale psychometric properties
TRS:A/YA version
Each of the original 36 items was examined to
determine its contribution to the scale. Items were
not omitted from analyses given their apparent
conceptual relevance. It is recommended that
items assessing construct-relevant information be
retained until measures can be evaluated across
broader samples (29). Given the skewness of the
data, items were entered into a non-parametric
PCA with varimax rotation. The joint criteria of
Eigen values>1 andCattells elbow criteria on the
scree plot (30) indicated that a four factor solution
accounted for 32.5% of the variance in responses.
We examined the number of specific items on
each factor that had loadings of >0.4, Factor 1,
labeled Demonstrated Skills, included 3/9 pro-
posed items (factor loadings range 0.73–0.85).
Factor 2, labeled Self-Management, contains 6/12
proposed items (factor loadings range: 0.60–0.77).
Factor 3, labeled Psychosocial Adjustment, con-
tains 3/11 proposed items (factor loadings range:
0.48–0.85). Factor 4, labeled Perceived Regimen
Knowledge, contains 2/10 proposed items (fac-
tor loadings: 0.69, 0.75). All domains of the
adolescent version of the TRS had acceptable
internal consistency, with Cronbach alphas ran-
ging from 0.68 to 0.81 (Table 2). The Cronbach
alpha for the entire 38-item adolescent versionwas
0.85.
TRS: parent version
Similar to the TRS:A/YA, each of the original
36 items was examined to determine its contri-
bution to the scale using the same procedure
outlined above. The results indicate that a four
factor solution accounted for 32.5% of the
Table 2. Descriptive statistics for domains of the TRS




Self management 26.23 4.98 7–35 0.68
AoR 11.75 2.95 0–15 0.80
Regimen knowledge 23.44 3.07 12–27 0.71
Demonstrated skills 19.42 4.79 0–26 0.81
Psychosocial adjustment 26.82 5.12 2–33 0.82
Total 95.90 14.78 28–117 0.85
Parent report (TRS:P)
Adolescent self-management 22.66 4.21 11–32 0.63
AoR 11.27 2.73 5–15 0.79
Adolescent regimen knowledge 18.26 2.32 9–21 0.60
Demonstrated skills 11.90 3.69 0–15 0.75
Adolescent psychosocial adjustment 26.21 3.38 17–32 0.56
Regimen knowledge 4.47 1.01 1–6 0.19
Total 83.48 9.13 56–97 0.75
Transition and adherence
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variance in responses. We examined the number
of specific items on each factor that had loadings
of >0.4. Factor 1, labeled Self-Management,
contains 5/11 proposed items (factor loading
range: 0.45–0.76). Factor 2, labeledDemonstrated
Skills, contains 4/5 proposed items (factor load-
ings range: 0.66–0.9). Factor 3, labeled Psychoso-
cial Adjustment, contains 4/11 proposed items
(factor loadings range: 0.41–0.84). Factor 4,
labeledAdolescentRegimenKnowledge, contains
4/7 proposed items (factor loadings range:
0.43–0.54). For the parent version, Cronbach
alphas ranged from 0.18 to 0.75 (Table 2). The
Cronbach alpha for the entire 36-item parent
version was 0.75.
Transition readiness scale descriptives
TRS:A/YA
The mean total score on the TRS:A/YA was 95.9
(76.1%, s.d.: 14.8), with a range of 28–117 (22.2–
92.9%). Each domain had a similarly wide range
of scores (Table 2). Most adolescents (90%)
correctly named their medications; however,
73% could not state dosages, 51% were unable
to specify prescribed timing between doses with a
minimum acceptable answer being some varia-
tion of ‘‘in the morning and at night,’’ and 41%
could not identify the basic function of their
immunosuppressants, with a minimum accept-
able answer being some variation of ‘‘they are for
my liver.’’
TRS:P
The mean total score on the TRS:P was 83.5
(77.3%; s.d.: 9.1), with a range of 56–97 (51.85–
89.8%). Each domain had a similarly wide range
of scores (Table 2).
Transition readiness and participant characteristics
Table 3 presents the correlations between the
TRS and participant characteristics. Age at
survey was positively correlated with the
TRS:A/AYA Total Score and domain scores
including Perceived Self-Management, Regimen
Knowledge, and Psychosocial Adjustment. Age
was also positively correlated with the TRS:
A/YA AoR subscale. Adolescent age was not
significantly related to Adolescent Demonstrated
Skills.
Of the 58 dyads, there were positive and
significant correlations between adolescent age
and TRS:P Total Score, including parent
reported domains assessing Adolescent Knowl-
edge, Adolescent Self-Management, and Adoles-
cent Psychosocial Adjustment. Age was also
positively correlated with the parent reported
AoR subscale. Adolescent age was not related to
Parent Demonstrated Skills or Parent Regimen
Knowledge.
To further explore the association between age
and the AoR subscale, we compared TRS:A/YA
and TRS:P scores across adolescents aged 11–13,
14–17, >18 yr. Based on adolescent self-reports,
the 11- to 13-yr-old age group was significantly
lower in their responsibility for health-related
tasks (mean = 9.5 ± 3.8) compared to the 14- to
17-yr-olds (mean = 12.2 ± 2.3, p = 0.002) and
>18-yr-olds (mean = 12.7 ± 2.4, p = 0.001).
There were no differences between the 14- to 17-
yr-olds and the >18-yr-old groups. Similarly,
based on parent reports, the 11- to 13-yr-old age
group was significantly lower in their responsi-
bility for health-related tasks (mean =
9.4 ± 3.0) compared to 14- to 17-yr-olds (mean
11.8 ± 2.3, p = 0.004) and >18-yr-olds
Table 3. Correlations between TRS, participant age, and adherence measures
Age Rate of attendance Cyclosporine s.d. IS out of range IS below range
Age r = )0.26; p = 0.03 r = 0.78; p = 0.005 r = 0.25; p = 0.03 –
Adolescent TRS
Total score rs = 0.51; p = 0.000 – – – –
Self-management rs = 0.44; p = 0.000 – rs = 0.72; p = 0.01 – rs = 0.27; p = 0.02
AoR subscale rs = 0.44; p = 0.000 – rs = 0.68; p = 0.02 – rs = 0.23; p = 0.05
Perceived regimen knowledge rs = 0.46; p = 0.000 – – – –
Demonstrated skills – – – – –
Psychosocial adjustment rs = 0.51; p = 0.000 – – – –
Parent TRS
Total score rs = 0.43; p = 0.001 – – – –
Adolescent self-management rs = 0.44; p = 0.001 – – – –
AoR subscale rs = 0.43; p = 0.001 – – – –
Adolescent regimen knowledge rs = 0.42; p = 0.001 – – – –
Demonstrated skills – – – – –
Adolescent psychosocial adjustment rs = 0.29; p = 0.026 – – – –
Regimen knowledge – rs = 0.40; p = 0.002 – – –
Fredericks et al.
948
(mean = 11.3 ± 2.7, p = 0.005). There were no
differences between the 14- to 17-yr-olds and the
>18-yr-old groups.
Adolescent age was significantly related to
time since transplantation, although time since
transplantation was not significantly related to
any domain of the TRS.
Adolescent/parent agreement
For the 58 dyads in which adolescent and parent
reports on the TRS were available, paired cor-
relations are as follows: Self-Management:
r = 0.47, p = 0.000; AoR: r = 0. 47, p =
0.000; Perceived Regimen Knowledge: r = 0.58,
p = 0.000; Adolescent Psychosocial Adjustment:
r = 0.47; p = 0.000; Demonstrated Skills: r =
)0.26, p = 0.84. With the exception of the
Demonstrated Skills domain, all correlations
are in the moderate agreement range.
Patterns of adherence
Table 4 displays descriptive statistics for the
adherence variables. Thirty-one percent
(n = 22) of adolescents were non-adherent using
s.d. of tacrolimus (s.d. > 2) or cyclosporine
(s.d. > 30) and 26.8% (n = 19) were non-
adherent based on having >50% of immuno-
suppressant laboratory values out of the target
range. Thirty-two percent (n = 23) of adoles-
cents were non-adherent as measured by clinic
attendance <85% over the preceding 12 months.
Overall, 43% of adolescents (n = 31) were
classified as adherent across all measures,
29.6% (n = 21) were classified as non-adherent
on one variable, 19.7% (n = 14) were classified
as non-adherent on two variables, and 7.0%
(n = 5) were classified as non-adherent on all
variables.
Participant age was significantly related to
measures of adherence with older adolescents
demonstrating lower rates of clinic attendance
(r = )0.26; p = 0.03), higher s.d. of cyclospor-
ine (r = 0.78; p = 0.005), and a higher propor-
tion of immunosuppressant blood levels >1 s.d.
out of the target range (r = 0.25; p = 0.03). The
association between adolescent age and tacroli-
mus s.d. was not significant (r = 0.24; p =
0.06). Follow-up univariate analyses indicated
significant differences between adolescents
<16 yr old and >16 yr old with respect to
measures of adherence. Compared to the youn-
ger adolescents, those who were >16 yr (n = 36)
had lower rates of clinic attendance (79% vs.
90%; p = 0.05), higher tacrolimus s.d. (2.69 vs.
1.58, p = 0.035), and a higher percentage of
immunosuppressant blood levels out of target
range (42% vs. 32%; p = 0.05).
Transition readiness domains and adherence
Table 3 presents correlations between the TRS
and measures of adherence. No significant asso-
ciations were found between the TRS: A/YA and
adherence as measured by tacrolimus s.d. or rate
of clinic attendance. The TRS:A/YA domains
measuring Adolescent Perceived Self-Manage-
ment was positively correlated with the percent-
age of immunosuppressant levels below the
target range, and cyclosporine s.d. Within the
Self-Management domain, the AoR subscale was
positively correlated with cyclosporine s.d. and
the percentage of immunosuppressant levels
below the target range. On the TRS:P scale,
there were no significant associations between
parent reports and adherence as measured by
tacrolimus or cyclosporine s.d., or immunosup-
pressant laboratory values out of target range.
However, the rate of clinic attendance was
significantly related to the TRS:P domain mea-
suring Parent Regimen Knowledge.
Health outcomes
Within the 12 months prior to participation, 20%
of the adolescents had been hospitalized at least
once, 15.5% underwent at least one liver biopsy,
and 1.4% had a documented biopsy-proven epi-
sode of rejection. Across all participants, there
were a total of 25 hospital admissions, 155
inpatient days, 12 liver biopsies, and one biopsy-
proven episode of rejection. In the year prior to
participation, average ALT was 50.7 (s.d. =
50.0), average AST was 48.26 (s.d. = 54.4), and
average TBili was 0.88 (s.d. = 0.94).
Transition readiness domains, adherence, and health outcomes
There were no significant associations between
TRS:P or TRS:A/YA and measures of health
outcomes. Significant associations were found
Table 4. Descriptive statistics for measures of adherence
Mean s.d. Range
Tacrolimus s.d. (n = 60) 2.12 2.05 0.32–11.45
Cyclosporine s.d. (n = 11) 23.81 10.76 8.0–42.0
Percent of immunosuppressant








Clinic attendance (%) 84.97 24.52 0.0–100.0
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between measures of adherence and health out-
comes. Average ALT levels for the year prior to
participation were significantly related to tacro-
limus s.d. (r = 0.41; p = 0.001) and percentage
of immunosuppressant laboratory values out of
target range (r = 0.33; p = 0.005). Average
AST levels for the year prior to participation
were also significantly associated with tacrolimus
s.d. (r = 0.42; p = 0.001), cyclosporine s.d.
(r = 0.61; p = 0.047) and percentage of immu-
nosuppressant laboratory values out of target
range (r = 0.28; p = 0.017). The number of
biopsies, which suggests increased concern for
rejection, was significantly related to the percent-
age of immunosuppressant laboratory values
out of target range (r = 0.34, p = 0.004) and
tacrolimus s.d. (r = 0.33, p = 0.01).
Discussion
Results of the current study indicate that nearly
30% of the participants were non-adherent with
their immunosuppressant medications, and over
30% were non-adherent to recommended clinic
visits. This is consistent with previous reports
that medication non-adherence is common
among adolescent transplant recipients (15, 31,
32). There was a significant association between
age and non-adherence, with older adolescents
and young adults demonstrating higher rates of
non-adherence compared to the younger chil-
dren. This is concerning as chronological age is
the most common criterion used to determine
readiness to transfer from pediatric to adult-
centered care, with 16–22 yr being the most
frequently cited age range to start the transition
process (33). As medication adherence and health
outcomes may both be affected by changes
associated with a transfer to a new medical
provider, this is a time of increased risk for
adolescent and young adult transplant recipients.
With respect to the assessment of transition
readiness, perceived self-management skills, per-
ceived regimen knowledge, and psychosocial
adjustment increased with chronological age.
Yet, the association between age and perfor-
mance on the demonstrated skills domain did not
reach statistical significance. This suggests that
while older adolescents and young adults may
perceive that they have sufficient regimen knowl-
edge and self-management skills, their chrono-
logical age is not associated with demonstrated
self-management skills, including the ability to
describe their medical regimen or the ability
to recognize critical health symptoms. The ability
to recognize symptoms and demonstrate when
and how to seek urgent medical care is cited as
an important component of the transition pro-
cess (5).
We hypothesized that higher TRS scores
would be associated with higher rates of adher-
ence. On the contrary, this study found that
increased scores on the A/YA self-management
skills scale were associated with higher rates of
medication non-adherence. Specifically, higher
scores on the self-management scale were
associated with higher cyclosporine s.d. and
increased proportion of immunosuppressant
blood values below target range, which is indic-
ative of suboptimal medication intake (22).
Within the self-management domain, increased
AoR for medication-related tasks to the A/YA
was also associated with higher proportion of
immunosuppressant blood levels below range.
Although older adolescents/young adults per-
ceived greater self-management, they were at
higher risk for medication non-adherence. More-
over, with increasing age, this population is being
monitored less by their parents/caregivers. Thus,
the transition of medication-related responsibil-
ities from parents to adolescents may not be
successful as evidenced by poor medication
adherence in the older adolescents/young adults.
Likewise, research has demonstrated that
increased parental monitoring is associated with
improved adherence and health outcomes in
other chronic illness groups, including adoles-
cents with diabetes (34), HIV (35), and asthma
(17). In addition, a recent report suggests that
adolescent liver transplant recipients are incon-
sistent with their health management tasks
(36).Thus, it is critical that attention be given to
the role of parental monitoring and supervision
of medication-related tasks during the transition
process as adolescents begin to demonstrate
mastery of health management tasks.
Parents knowledge of the adolescents medical
regimen was significantly correlated with the rate
of clinic attendance. It is possible that the rate of
clinic attendance is a measure of parental adher-
ence to the regimen rather than the A/YAs
adherence. Further research to investigate the
impact of adolescent clinic attendance without
their parent on transition readiness and adher-
ence is warranted, particularly as it relates to the
allocation of regimen responsibility.
The results of this study should be viewed in
light of study limitations. The TRS used in this
study was developed for clinical use to guide
intervention. This was not a prospective mea-
surement development study, thus the construct
and content validity of the TRS were not
investigated prior to its administration for
Fredericks et al.
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clinical purposes. Moreover, given the retrospec-
tive nature of this study, the predictive validity of
the TRS as it relates to medication adherence
andsuccessful transferofcare isnotknown.Lastly,
this retrospective, cross-sectional study was con-
ducted within a single pediatric liver transplant
program which limits generalizability. Within
this single center study, relatively few partici-
pants were receiving cyclosporine as their pri-
mary immunosuppressant medication (n = 11).
Thus, the significant association between higher
cyclosporine s.d. and higher perceived self-
management skills should be interpreted with
caution. Further multi-center study of the asso-
ciation between medication adherence as mea-
sured by immunosuppressant variability and
transition readiness skills is warranted.
Unfortunately, while many clinical programs
strive to enhance the acquisition of self-manage-
ment skills in adolescents, they do not routinely
assess transition readiness, including the ability
to independently manage health care needs (37,
38). One barrier to the routine assessment of
transition skills may relate to the lack of a
validated instrument to assess transition-related
self-management skills. There is a critical need
for the development and validation of objective
assessment tools to empirically evaluate the
pediatric patients readiness to move from a
pediatric to adult-focused transplant health care.
We are presently revising the TRS by conducting
additional quantitative analyses as well as qual-
itative research with key informants regarding
areas of transition which need further develop-
ment. These data will inform the development of
a revised TRS which will be piloted with a
broader sample of A/YA transplant recipients
across transplant centers. Future research will
also incorporate other measures of self-manage-
ment, allocation of health care responsibility,
and health outcomes, to evaluation the concur-
rent and predictive validity of the TRS. This will
allow for the refinement of questions and
domains within the instrument.
Limitations aside, this study has notable clin-
ical implications. The current literature recom-
mends that medical stability is a critical variable
in the transfer from pediatric to adult-centered
care (5, 39). Given that medication non-adher-
ence is associated with increased risk for medical
complications, particularly among adolescent
transplant recipients (40, 41), targeting problems
of medication non-adherence should be an
essential component of the transition process.
While medication adherence may not be suffi-
cient for optimal health care transitions, it is an
essential component.
Self-management interventions are effective in
promoting medication adherence in children with
other chronic health conditions (42, 43), and
there is increasing recognition that self-manage-
ment skills should be the goal of any transition
program (11, 12). Interventions to promote
transition readiness should also target parental
monitoring and the transition of responsibility of
health-related tasks from the parent to the
A/YA. The inverse relationship between medica-
tion adherence and perceived self-management
skills suggests that although adolescents perceive
that they have adequate knowledge and manage-
ment skills, they are not demonstrating the skills
necessary for optimal medication management.
This may relate to a variety of individual, family,
and/or provider factors including motivation,
health literacy, and communication with health
care provider. In addition, the role of peer
support has been suggested to be an important
factor for adolescents and young adults transi-
tioning from pediatric to adult-centered care
(5, 39). This study did not investigate the impact
of peer and social support on medication adher-
ence or transition-related skills. We are currently
conducting prospective studies to examine fac-
tors that relate to medication adherence and self-
management skills throughout the transition
process.
Using this clinical tool, we have developed a
transition program in our clinic which involves
patient and parent education, behavioral goals
and skill building and systematic planning for the
transfer to adult care. Clinic-based adherence
interventions incorporate educational, motiva-
tional, behavioral, and organizational strategies
to foster the acquisition of self-management
skills. We are currently engaged in ongoing
quality improvement efforts to evaluate the
effectiveness of our programs to promote med-
ication adherence and transition skills in a
systematic and developmentally appropriate
manner.
Conclusions
Medication adherence is a key factor in the
transition from pediatric to adult-centered
transplant care. This study demonstrated that
chronological age was associated with perceived
self-management skills, yet older age was associ-
ated with increased risk for non-adherence. Thus,
despite increased independence over health-
related tasks, age alone should not determine
readiness to transfer from pediatric to adult-
focused health care given the risk of medical
complications. Rather, the timing of transfer
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from pediatric to adult-focused care should be
individualized and based on the acquisition and
mastery of self-management skills. Medication
non-adherence is associated with an increased risk
for medical complications including graft loss and
rejection. Therefore, the promotion of medication
adherence should be an essential component of
transition planning. Interventions to promote
transition readiness should also target parental
monitoring and the developmentally appropriate
transition of responsibility of health-related tasks
from the parent to the A/YA.
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